MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1507/endocrj.ej21-0584

Медицинская библиотека · Endocrine journal · 2022

Increased brain-derived neurotrophic factor in the serum of persons with nonalcoholic fatty liver disease.

Hattori Yuji, Yamada Hiroya, Munetsuna Eiji, Ando Yoshitaka, Mizuno Genki, Fujii Ryosuke, Tsuboi Yoshiki, Ichino Naohiro, Osakabe Keisuke, Sugimoto Keiko, Ishikawa Hiroaki, Ohashi Koji, Suzuki Koji

СтатьяПеревод в очереди

Аннотация

The increasing prevalence of nonalcoholic fatty liver disease (NAFLD) is a global health problem. In recent years, the inhibitory effect of brain-derived neurotrophic factor (BDNF) on diabetes mellitus and fatty liver has been clarified. The purpose of this study was to analyze the relationship between serum BDNF and NAFLD which caused by abnormal metabolism of glucose and lipids. This cross-sectional study involved 429 participants (mean age, 63.5 years: men, 38.5%) with low alcohol intake. Of the participants, those who had an increase in echogenicity of the liver parenchyma and hepato-renal contrast on ultrasonography were classified as the NAFLD group (n = 88), and the others were classified as the normal (n = 341) group. The NAFLD group was further classified into a mild group (n = 60) and a severe group (n = 28) based on the intensity of echogenicity and visualization of the hepatic vessels and diaphragm. Median BDNF levels were higher in the NAFLD group than the normal group (35.5 vs. 42.3 ng/mL, p < 0.01). Furthermore, BDNF levels tended to be associated with the severity of NAFLD (p < 0.01). In addition to the univariate analysis, in the sex- and age-adjusted model, there was a significant association between the BDNF levels and NAFLD severity (p < 0.01). The fully adjusted regression analysis also showed a positive association between the serum BDNF level and NAFLD (p < 0.01). These results suggest that NAFLD patients have a compensatory increase in circulating BDNF levels.

Для цитирования: Hattori Yuji, Yamada Hiroya, Munetsuna Eiji, Ando Yoshitaka, Mizuno Genki, Fujii Ryosuke, Tsuboi Yoshiki, Ichino Naohiro, Osakabe Keisuke, Sugimoto Keiko, Ishikawa Hiroaki, Ohashi Koji, Suzuki Koji. Increased brain-derived neurotrophic factor in the serum of persons with nonalcoholic fatty liver disease.. Endocrine journal. 2022. DOI: 10.1507/endocrj.ej21-0584.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.